CCL26 and gastroesophageal reflux disease: To our surprise, we found that PPI treatment significantly decreased eotaxin-3 expression (which correlated with eosinophil count) only in the proximal esophagus, even though PPI effects in reducing acid reflux are strongest in the distal esophagus.